Salarius Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:FP10 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
26 Oct 23	Buy€155,180	Elvin Lee	Individual		25,533.75	€6.08

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 216.6%.

Top 20 shareholders own 4.34% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
1.77%	Elvin Lee	25,534	€44.9k	0%	no data
1.58%	Armistice Capital LLC	22,750	€40.0k	117%	no data
0.43%	David Arthur	6,142	€10.8k	0%	no data
0.22%	Tower Research Capital Europe Limited	3,178	€5.6k	202%	no data
0.19%	Mark Rosenblum	2,731	€4.8k	0%	no data
0.029%	Arnold Hanish	412	€724.7	0%	no data
0.026%	Jonathan Lieber	368	€647.4	0%	no data
0.025%	William McVicar	356	€626.1	0%	no data
0.024%	Tess Burleson	340	€598.0	0%	no data
0.015%	Paul Lammers	215	€378.2	0%	no data
0.012%	Bruce McCreedy	180	€316.6	-19.6%	no data
0.011%	Woodbury Financial Services, Inc, Securities Investments	163	€286.7	0%	no data
0.0078%	UBS Asset Management AG	113	€198.7	5,550%	no data
0.0037%	Advisor Group Holdings, Inc., Asset Management Arm	53	€93.3	0%	no data
0.00069%	Securities America Advisors, Inc.	10	€17.5	0%	no data
0.00049%	Morgan Stanley, Investment Banking and Brokerage Investments	7	€12.4	0%	no data
0.00028%	Bank of America Corporation, Asset Management Arm	4	€7.1	0%	no data
0.00014%	Merrill Lynch & Co. Inc., Banking Investments	2	€3.5	0%	no data
0.00007%	BlackRock, Inc.	1	€1.8	0%	no data
0.00007%	Wells Fargo & Company, Securities and Brokerage Investments	1	€1.8	0%	no data